Clinical Trial: Human Fibrinogen Concentrate in Pediatric Cardiac Surgery

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: The Role of Human Fibrinogen Concentrate (RiaSTAP) in Decreasing the Need for Component Blood Therapy in Infants Undergoing Cardiopulmonary Bypass.

Brief Summary: The goal of the study is to determine whether the use of Human Fibrinogen Concentrate (RiaSTAP) will decrease the need for component blood therapy in neonates and infants undergoing cardiopulmonary bypass.